PUBLISHER: The Business Research Company | PRODUCT CODE: 1946680
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946680
Orthopedic biomaterials are substances developed to be implanted in the human body as parts of medical devices designed to perform specific biological functions by replacing or repairing different tissues such as bones, cartilage, ligaments, tendons, and others.
The orthopedic biomaterials market covered in this report is segmented by material type into ceramics and bioactive glasses, calcium phosphate cement, polymers, metals, and composites. Polymers used as orthopedic biomaterials are intended for implantation into the human body as functional components. The applications include orthopedic implants, joint replacement or reconstruction, bioresorbable tissue fixation, orthobiologics, and viscosupplementation, and these materials are used by end users such as hospitals, clinics, and others.
Tariffs have influenced the orthopedic biomaterials market by increasing costs of imported metals, ceramics, and polymers used in implants and fixation systems. Joint replacement and bio-resorbable fixation segments are most affected, particularly in North America and Europe. Positively, tariffs are driving localized production, material innovation, and supplier diversification to stabilize pricing and supply chains.
The orthopedic biomaterials market research report is one of a series of new reports from The Business Research Company that provides orthopedic biomaterials market statistics, including orthopedic biomaterials industry global market size, regional shares, competitors with a orthopedic biomaterials market share, detailed orthopedic biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic biomaterials industry. This orthopedic biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The orthopedic biomaterials market size has grown rapidly in recent years. It will grow from $22.6 billion in 2025 to $25.9 billion in 2026 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to aging population growth, rising orthopedic injuries, expansion of joint replacement surgeries, availability of metallic implants, hospital infrastructure development.
The orthopedic biomaterials market size is expected to see strong growth in the next few years. It will grow to $36.67 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to growth in sports injuries, demand for personalized implants, increasing osteoarthritis prevalence, advancements in composite biomaterials, rising healthcare expenditure. Major trends in the forecast period include rising use of bioactive materials, growing demand for joint replacement solutions, increased adoption of lightweight implants, expansion of minimally invasive orthopedic procedures, focus on long-term implant durability.
The rise in the incidence of musculoskeletal disorders is increasingly supporting the expansion of the orthopedic biomaterials market. Musculoskeletal disorders cause fractures, inflammation, pain, and discomfort in joints, ligaments, and tendons, often leading to movement limitations and disability. The burden of musculoskeletal conditions increases significantly with age, as degenerative changes become more common in older populations. For example, in January 2024, according to GOV.UK, a UK-based government department, 18.4% of individuals aged 16 years and older reported having a long-term musculoskeletal condition in 2023, up from 17.6% in 2022. Consequently, the growing incidence of musculoskeletal disorders is reinforcing demand for orthopedic biomaterials.
Leading companies operating in the orthopedic biomaterials market are focusing on innovative products, such as tendon fixation devices, to drive market revenues. A tendon fixation device is an orthopedic implant used to secure tendons, ligaments, or soft tissue to bone during surgical procedures. For example, in June 2023, Acuitive Technologies Inc., a US-based developer of orthopedic biomaterial technologies, launched a new tendon fixation device for anterior cruciate ligament repair. The device features a tendon-friendly spiral thread made from Citregen, a next-generation resorbable material engineered to support natural healing while reducing chronic inflammation commonly associated with other biodegradable devices.
In September 2023, Enovis, a US-based medical technology company, acquired Lima Corporate for $847 million. Enovis expects the acquisition to deliver several strategic benefits, including the opportunity to expand its successful reconstruction portfolio and strengthen its global presence. The transaction is anticipated to support improved financial performance through cross-selling revenue opportunities and cost efficiencies. Lima Corporate is an Italy-based manufacturer of orthopedic biomaterials.
Major companies operating in the orthopedic biomaterials market are Medtronic PLC, Johnson & Johnson, Stryker Corporation, Zimmer Biomet, Smith & Nephew, NuVasive, Wright Medical Group N.V., Orthofix Medical Inc., Acelity, Conmed Corporation, Aesculap, Seaspine Holdings Corporation, Bone Support AB, Bioventus, K2M Group Holdings Inc., MTF Biologics, Amedica Corporation, TPL Biomed, Fidia Farmaceutici S.p.A., OsteoRemedies, Xtant Medical, RTI Surgical Holdings Inc., LifeNet Health, VIVEX Biologics, DJO Global, MedShape, Evonik Industries AG, Heraeus Medical, 3M Company, Collagen Solutions plc
North America was the largest region in the orthopedic biomaterials market in 2025. Western Europe was the second largest region in the orthopedic biomaterials market report. The regions covered in the orthopedic biomaterials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the orthopedic biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The orthopedic biomaterials market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Orthopedic Biomaterials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses orthopedic biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for orthopedic biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The orthopedic biomaterials market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.